HY Stock Analysis: Hyster-Yale Materials | NYSE
Farm & Heavy Construction Machinery | NYSE, USA | Market Cap: 573m USD | 12M Return: -20.1% | Charts, Fundamentals & Technical Analysis
Avg Turnover: 3.45M
Qual. Beats: 0
Rev. Trend: -52.3%
Qual. Beats: -1
Warnings
Tailwinds
No distinct edge detected
Seasonality 10.5 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Hyster-Yale, Inc. is a global provider of lift trucks, attachments, parts, fleet management services, and technology and energy solutions. The company manufactures key components such as frames, masts, and transmissions, and assembles its own lift trucks. It operates a multi-brand strategy, marketing products under the Hyster, Yale, and Nuvera names and selling through an independent retail dealership network. Additional offerings include lift truck attachments under the Bolzoni, Auramo, and Meyer brands, parts under the UNISOURCE brand, and specialized equipment for port and rough terrain applications.
Headquartered in Cleveland, Ohio, and incorporated in 1991, the company trades on the NYSE under the ticker HY. It is classified within the Industrials sector, specifically the Industrial Machinery & Supplies & Components sub-industry. Hyster-Yales business model combines in-house component manufacturing with branded distribution, serving a wide range of end markets from light-duty warehousing to heavy port operations and rough terrain material handling.
- EMEA lift truck orders decline on weak industrial demand
- Operating margins compress from pricing and cost inflation
- Nuvera hydrogen investment pressures near-term profitability
| Net Income: -99.2m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.01 > 0.02 and ΔFCF/TA -1.54 > 1.0 |
| NWC/Revenue: 8.54% < 20% (prev 9.63%; Δ -1.09% < -1%) |
| CFO/TA 0.05 > 3% & CFO 89.6m > Net Income -99.2m |
| Net Debt/EBITDA: error (EBITDA <= 0) |
| Current Ratio: 1.31 > 1.5 & < 3 |
| Outstanding Shares: last quarter (17.8m) vs 12m ago 0.31% < -2% |
| Gross Margin: 15.83% > 18% (prev 20.23%; Δ -4.40% > 0.5%) |
| Asset Turnover: 182.1% > 50% (prev 202.5%; Δ -20.41% > 0%) |
| Interest Coverage Ratio: -1.46 > 6 (EBIT TTM -54.5m / Interest Expense TTM 37.3m) |
| A: 0.16 (Total Current Assets 1.31b - Total Current Liabilities 992.9m) / Total Assets 1.96b |
| B: 0.13 (Retained Earnings 252.2m / Total Assets 1.96b) |
| C: -0.03 (EBIT TTM -54.5m / Avg Total Assets 2.01b) |
| D: 0.29 (Book Value of Equity 430.1m / Total Liabilities 1.51b) |
| Altman-Z'' = 1.58 = BB |
| DSRI: 1.06 (Receivables 471.2m/506.1m, Revenue 3.65b/4.16b) |
| GMI: 1.28 (GM 20.23% / 15.83%) |
| AQI: 1.19 (AQ_t 0.17 / AQ_t-1 0.14) |
| SGI: 0.88 (Revenue 3.65b / 4.16b) |
| TATA: -0.10 (NI -99.2m - CFO 89.6m) / TA 1.96b) |
| Beneish M = -2.71 (Cap -4..+1) = A |
As of July 11, 2026, the stock is trading at USD 32.68 with a total of 80,807 shares traded. Over the past week, the price has changed by +2.16%, over one month by -3.60%, over three months by -9.36% and over the past year by -20.08%.
Current recommended Stop Loss: 30.20 (which is 7.6% or 1.4 ATR below the current price).
Hyster-Yale Materials has received a consensus analysts rating of 3.50. Therefore, it is recommended to hold HY.
- StrongBuy: 0
- Buy: 1
- Hold: 1
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 46 | 40.8% |
P/E Forward = 13.0548
P/S = 0.1568
P/B = 1.3326
P/EG = 1.61
Revenue TTM = 3.65b USD
EBIT TTM = -54.5m USD
EBITDA TTM = -8.40m USD
Long Term Debt = 251.1m USD (from longTermDebt, last quarter)
Short Term Debt = 254.2m USD (from shortTermDebt, last quarter)
Debt = 674.1m USD (from shortLongTermDebtTotal, last quarter) + Leases 168.8m
Net Debt = 592.3m USD (calculated: Debt 674.1m - CCE 81.8m)
Enterprise Value = 1.17b USD (573.1m + Debt 674.1m - CCE 81.8m)
Interest Coverage Ratio = -1.46 (Ebit TTM -54.5m / Interest Expense TTM 37.3m)
EV/FCF = 41.77x (Enterprise Value 1.17b / FCF TTM 27.9m)
FCF Yield = 2.39% (FCF TTM 27.9m / Enterprise Value 1.17b)
FCF Margin = 0.76% (FCF TTM 27.9m / Revenue TTM 3.65b)
Net Margin = -2.71% (Net Income TTM -99.2m / Revenue TTM 3.65b)
Gross Margin = 15.83% ((Revenue TTM 3.65b - Cost of Revenue TTM 3.08b) / Revenue TTM)
Gross Margin QoQ = 15.92% (prev 14.25%)
Tobins Q-Ratio = 0.60 (Enterprise Value 1.17b / Total Assets 1.96b)
Interest Expense / Debt = 5.53% (Interest Expense 37.3m / Debt 674.1m)
Taxrate = 21.0% (US federal default 21%)
NOPAT = -43.1m (EBIT -54.5m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 1.31 (Total Current Assets 1.31b / Total Current Liabilities 992.9m)
Debt / Equity = 1.57 (Debt 674.1m / totalStockholderEquity, last quarter 430.1m)
Debt / EBITDA = -70.51 (negative EBITDA) (Net Debt 592.3m / EBITDA -8.40m)
Debt / FCF = 21.23 (Net Debt 592.3m / FCF TTM 27.9m)
Total Stockholder Equity = 495.7m (last 4 quarters mean from totalStockholderEquity)
RoA = -4.94% (Net Income -99.2m / Total Assets 1.96b)
RoE = -20.01% (Net Income TTM -99.2m / Total Stockholder Equity 495.7m)
RoCE = -7.30% (EBIT -54.5m / Capital Employed (Equity 495.7m + L.T.Debt 251.1m))
RoIC = -3.78% (negative operating profit) (NOPAT -43.1m / Invested Capital 1.14b)
WACC = 7.79% (E(573.1m)/V(1.25b) * Re(11.82%) + D(674.1m)/V(1.25b) * Rd(5.53%) * (1-Tc(0.21)))
Discount Rate = 11.82% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 53.94 | Cagr: 0.84%
[DCF] Terminal Value 73.10% ; FCFF base≈41.1m ; Y1≈36.1m ; Y5≈29.1m
[DCF] Fair Price = N/A (negative equity: EV 467.9m - Net Debt 592.3m = -124.4m; debt exceeds intrinsic value)
EPS Correlation: N/A | EPS CAGR: N/A | SUE: 0.19 | # QB: 0
Revenue Correlation: -52.33 | Revenue CAGR: -2.97% | SUE: -1.98 | # QB: -1
EPS current Quarter (2026-06-30): EPS=-1.13 | Chg30d=+3.42% | Revisions=-25% | Analysts=1
EPS next Quarter (2026-09-30): EPS=0.11 | Chg30d=+184.62% | Revisions=+25% | Analysts=2
EPS current Year (2026-12-31): EPS=-3.93 | Chg30d=-33.67% | Revisions=+0% | GrowthEPS=-119.5% | GrowthRev=-6.3%
EPS next Year (2027-12-31): EPS=2.07 | Chg30d=+113.40% | Revisions=-25% | GrowthEPS=+128.5% | GrowthRev=+9.1%
[Analyst] Revisions Ratio: -17% (up=1, down=2)